tradingkey.logo
搜索

Psyence Biomedical Ltd

PBM
添加自选
3.190USD
-0.170-5.06%
收盘 07-31 16:00美东报价延迟15分钟
36.38K总市值
亏损市盈率 TTM

关于 Psyence Biomedical Ltd 公司

Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Psyence Biomedical Ltd简介

公司代码PBM
公司名称Psyence Biomedical Ltd
上市日期Dec 10, 2021
CEOMaresky (Neil)
员工数量12
证券类型Ordinary Share
年结日Dec 10
公司地址121 Richmond Street West Penthouse
城市TORONTO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Canada
邮编M5H 2K1
电话17744604171
网址
公司代码PBM
上市日期Dec 10, 2021
CEOMaresky (Neil)

Psyence Biomedical Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
1.56K
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
885.00
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
491.00
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Neil Maresky
Dr. Neil Maresky
Chief Executive Officer, Director
Chief Executive Officer, Director
1.56K
--
Dr. Jody Aufrichtig
Dr. Jody Aufrichtig
Chairman of the Board, Strategic Business Development Officer
Chairman of the Board, Strategic Business Development Officer
885.00
--
Mr. Warwick Corden-Lloyd
Mr. Warwick Corden-Lloyd
Chief Financial Officer
Chief Financial Officer
491.00
--
Mr. Marc Balkin
Mr. Marc Balkin
Independent Director
Independent Director
--
--
Mr. Christopher (Chris) Bull
Mr. Christopher (Chris) Bull
Independent Director
Independent Director
--
--
Dr. Seth Feuerstein
Dr. Seth Feuerstein
Independent Director
Independent Director
--
--

常见问题

Psyence Biomedical Ltd的前五大股东是谁?

Psyence Biomedical Ltd 的前五大股东如下:Dr. Neil Maresky

有多少机构持有Psyence Biomedical Ltd(PBM)的股份?

截至2026Q1,共有24家机构持有Psyence Biomedical Ltd的股份,合计持有的股份价值约为159.81K,占公司总股份的6.96%。与2025Q4相比,机构持股有所增加,增幅为112677.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有